THERAPEUTIC DLL4 BINDING PROTEINS

    公开(公告)号:ZA201206552B

    公开(公告)日:2013-05-29

    申请号:ZA201206552

    申请日:2012-08-31

    Applicant: ABBOTT LAB

    Abstract: DLL4 binding proteins are described herein, including antibodies, CDR-grafted antibodies, humanized antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 and/or VEGF activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis.

Patent Agency Ranking